Downregulation of miR-503 contributes to the development of drug resistance in ovarian cancer by targeting PI3K p85
Crossref DOI link: https://doi.org/10.1007/s00404-018-4649-0
Published Online: 2018-01-11
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wu, Di
Lu, Pan
Mi, Xue
Miao, Jinwei http://orcid.org/0000-0002-9939-004X
Funding for this research was provided by:
Beijing Natural Science Foundation (7162063)
License valid from 2018-01-11